![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1873-5592|14|12|1508-1521
ISSN: 1389-4501
Source: Current Drug Targets, Vol.14, Iss.12, 2013-11, pp. : 1508-1521
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Anti-IL-13 in Inflammatory Bowel Disease: From the Bench to the Bedside
Current Drug Targets, Vol. 14, Iss. 12, 2013-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Cytokine and Anti-cytokine Therapies for Inflammatory Bowel Disease
Current Pharmaceutical Design, Vol. 9, Iss. 14, 2003-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
IL-17F, a target for anti-cytokine therapy
By Maitra Amarnath Gaffen Sarah L
Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 4, 2007-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Smad7 and its Potential as Therapeutic Target in Inflammatory Bowel Diseases
Current Drug Metabolism, Vol. 17, Iss. 3, 2016-03 ,pp. :